5. UC-MSCs After Trochlear Groove Reconstruction in Dogs
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
5. UC-MSCs After Trochlear Groove Reconstruction in Dogs
-
Narrated by:
-
By:
About this listen
This week on Sit. Stay. Learn., I reviewed a 2022 study by He et al. in Frontiers in Veterinary Science that tested whether umbilical cord-derived mesenchymal stem cells (UC-MSCs) could improve recovery after trochlear groove reconstruction (TGR) in dogs. Ten healthy poodles were divided into treatment and control groups, with UC-MSCs injected intra-articularly on days 0, 7, and 14. The treated dogs showed significantly lower white blood cell and neutrophil counts on days 7 and 21, indicating less inflammation, and recovered mobility about four days faster than controls. CT and histology revealed early cartilage regeneration and restored bone contour in the UC-MSC group, while controls still had cartilage gaps. Overall, UC-MSCs appeared to reduce inflammation, speed healing, and improve joint repair without adverse effects. Since these were donor (allogeneic) cells, I’d like to see future work confirm long-term safety—one reason I often favor autologous options like Ardent’s SVF therapy. If you’ve used PRP or cell therapy in a TGR case, I’d love to hear your results at adrienne@ardentanimalhealth.com or www.ardentanimalhealth.com.